At 65 days of age, the different metabolic pathways were lysine degradation, non-alcoholic fatty liver disease, insulin signaling pathway, nicotinate and nicotinamide metabolism, and pentose phosphate pathway (Figure 10A). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.